Bora Pharmaceuticals Co. Ltd (BORAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Sales | 610,355 | 598,548 |
| Cost of Goods | 358,273 | 358,758 |
| Gross Profit | 252,082 | 239,790 |
| Operating Expenses | 146,632 | 135,348 |
| Operating Income | 105,723 | 105,200 |
| Interest Expense | 15,556 | 14,919 |
| Other Income | 79,254 | 63,820 |
| Pre-tax Income | 169,420 | 154,100 |
| Income Tax | 26,638 | 28,443 |
| Net Income Continuous | 142,782 | 125,657 |
| Net Income Discontinuous | -45,004 | N/A |
| Minority Interests | 2,078 | 3,153 |
| Net Income | $95,700 | $122,503 |
| EPS Basic Total Ops | 0.15 | 0.24 |
| EPS Basic Continuous Ops | 0.23 | 0.25 |
| EPS Basic Discontinuous Ops | -0.07 | N/A |
| EPS Diluted Total Ops | 0.15 | 0.22 |
| EPS Diluted Continuous Ops | 0.21 | 0.22 |
| EPS Diluted Discontinuous Ops | -0.07 | N/A |
| EBITDA(a) | $140,601 | $137,118 |